Clinical variables as prognostic tools in pediatric-onset ulcerative colitis: A retrospective cohort study

Inflammatory Bowel Diseases

Volumn 17, Issue 1, 2011, Pages 15-21

  Moore, Jill C ^a   Thompson, Kimberly ^a   Lafleur, Bonnie ^b   Book, Linda S ^a   Jackson, W Daniel ^a   O'Gorman, Molly A ^a   Black, Richard E ^a   Downey Jr , Earl ^a   Johnson, Dale G ^a   Matlak, Michael E ^a   Meyers, Rebecka L ^a   Scaife, Eric ^a   Guthery, Stephen L ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

colectomy; pediatric onset; ulcerative colitis

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; INFLIXIMAB;

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD DISEASE; COHORT ANALYSIS; COLON RESECTION; DISEASE ASSOCIATION; ENTERITIS; FEMALE; HEMATOCRIT; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCHOOL CHILD; ULCERATIVE COLITIS;

ADOLESCENT; CHILD; COHORT STUDIES; COLECTOMY; COLITIS, ULCERATIVE; HUMANS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 78650140197     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21393     Document Type: Article

References (26)

1. Benchimol E, Guttmann A, Griffiths A, et al. Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data. Gut. 2009; 58: 1490-1497.
2. Kappelman MD, Rifas-Shiman SL, Porter CQ, et al. Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology. 2008; 135: 1907-1913.
3. Gower-Rousseau C, Dauchet L, Vernier-Massouille G, et al. The natural history of pediatric ulcerative colitis: a population-based cohort study. Am J Gastroenterol. 2009; 104: 2080-2088.
4. Howarth LJ, Wiskin AE, Griffiths DM, et al. Outcome of childhood ulcerative colitis at 2 years. Acta Paediatr. 2007; 96: 1790-1793.
5. Vanlimbergen J, Russell R, Drummond H, et al. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology. 2008; 135: 1114-1122.
6. Guthery S, Dong L, Dean J, et al. US estimates of hospitalized pediatric patients with ulcerative colitis: implications for multicenter clinical studies. Inflamm Bowel Dis. 2008; 14: 1253-1258.
7. Guthery SL, Gross TG,. Assessing the risk of Epstein-Barr virus-related lymphoproliferative disorders before administration of visilizumab. Gastroenterology. 2008; 134: 895-896.
8. Guthery SL, Heubi JE, Bucuvalas JC, et al. Determination of risk factors for Epstein-Barr virus-associated posttransplant lymphoproliferative disorder in pediatric liver transplant recipients using objective case ascertainment. Transplantation. 2003; 75: 987-993.
9. Norlin C, Osborn LM,. Organizational responses to managed care: issues for academic health centers and implications for pediatric programs. Pediatrics. 1998; 101: 805-811; discussion 811-802.
10. Ward L, Ashdown N,. Census brief: age distribution in Utah. Second in a Series of Census 2000 Analyses. 2001. Available at
11. Wang TJ, Gona P, Larson MG, et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med. 2006; 355: 2631-2639.
12. Ware JH,. The limitations of risk factors as prognostic tools. N Engl J Med. 2006; 355: 2615-2617.
13. Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000; 31: 864-871.
14. Fonarow GC, Adams KF, Abraham WT, et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA. 2005; 293: 572-580.
15. Perkins NJ, Schisterman EF,. The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol. 2006; 163: 670-675.
16. Ambalavanan N, Carlo WA, Bobashev G, et al. Prediction of death for extremely low birth weight neonates. Pediatrics. 2005; 116: 1367-1373.
17. Turner D, Otley A, Mack D, et al. Development, validation, and evaluation of a Pediatric Ulcerative Colitis Activity Index: a prospective multicenter study. Gastroenterology. 2007; 133: 423-432.
18. Turner D, Walsh CM, Benchimol EI, et al. Severe paediatric ulcerative colitis: incidence, outcomes, and optimal timing for second line therapy. Gut. 2008; 57: 331-338.
19. Borowitz MJ, Devidas M, Hunger SP, et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study. Blood. 2008; 111: 5477-5485.
20. Riis L, Vind I, Vermeire S, et al. The prevalence of genetic and serologic markers in an unselected European population-based cohort of IBD patients. Inflamm Bowel Dis. 2007; 13: 24-32.
21. Mamula P, Telega GW, Markowitz JE, et al. Inflammatory bowel disease in children 5 years of age and younger. Am J Gastroenterol. 2002; 97: 2005-2010.
22. Sandborn WJ, Loftus EV, Colombel JF, et al. Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease. Inflamm Bowel Dis. 2001; 7: 192-201.
23. Paynter NP, Chasman DI, Buring JE, et al. Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3. Ann Intern Med. 2009; 150: 65-72.
24. Meigs J, Shrader P, Sullivan L, et al. Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med. 2008; 359: 2208-2219.
25. Hyams JS, Davis P, Grancher K, et al. Clinical outcome of ulcerative colitis in children. J Pediatr. 1996; 129: 81-88.
26. Falcone R, Lewis L, Warner B,. Predicting the need for colectomy in pediatric patients with ulcerative colitis. J Gastrointest Surg. 2000; 4: 201-206.